All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0492 | Anti-CFDP1 (CBXC-0381) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBXC-0381 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3916 | Anti-CFDP1 (CBXC-0381) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBXC-0381 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2870 | Anti-CFDP1 (CBFYC-1755) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-1755 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6123 | Anti-CFDP1 (CBFYC-1755) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBFYC-1755 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0465 | Anti-CFDP1 (CBWJC-2526) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBWJC-2526 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0466 | Anti-CFDP1 (CBWJC-2527) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBWJC-2527 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0467 | Anti-CFDP1 (CBWJC-2528) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBWJC-2528 | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2757 | Anti-CFDP1 (CBWJC-2526) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBWJC-2526 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2758 | Anti-CFDP1 (CBWJC-2527) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBWJC-2527 | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2759 | Anti-CFDP1 (CBWJC-2528) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | Human | CBWJC-2528 | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION